STAT3 Contributes to the Mitogenic Response of Hepatocytes during Liver Regeneration
Open accessAbstract
STAT3 is rapidly induced during liver regeneration in an interleukin 6 (IL-6)-dependent fashion, and IL-6 is required for normal liver regeneration. We wanted to know whether STAT3 was also required for liver regeneration but disruption of the STAT3 gene during embryonic stages causes lethality. Therefore, an albumin promoter-driven Cre-loxP recombination system was used to create a STAT3 deletion in the adult mouse liver to study the role of STAT3 in liver regeneration. After partial hepatectomy, there was virtually no STAT3 RNA or protein induction in Alb(+) STAT3(fl/fl) livers. STAT3 DNA binding activity was also absent in Alb(+) STAT3(fl/fl) livers. Unlike in control livers, STAT1 was activated in STAT3 conditional-mutant livers posthepatectomy. Hepatocyte DNA synthesis at 40 h posthepatectomy in Alb(+) STAT3(fl/fl) livers was reduced to approximately one-third of the control. Alb(+) STAT3(fl/fl) livers had abnormalities in immediate-early gene activation that largely correlated with but were not identical to those seen in IL-6-/- livers. G(1) phase cyclins including cyclins D1 and E had lower expression levels in Alb(+) STAT3(fl/fl) livers, indicating an abnormal G(1) to S phase transition. Therefore, STAT3 accounts for part of the DNA synthetic response of the hepatocytes during liver regeneration, which cannot be compensated for by induction of STAT1. Normal activation of the MAPK pathway in Alb(+) STAT3(fl/fl) livers reinforces the fact that at least part of the effect of IL-6 on hepatocyte proliferation is not mediated by STAT3. This study provides the first in vivo evidence that STAT3 promotes cell cycle progression and cell proliferation under physiological growth conditions.
AI snapshot
Written from the paper’s full text.
TL;DR
Using an albumin promoter–driven Cre-loxP system to delete STAT3 in adult mouse liver, this study shows that STAT3 is required for part of the hepatocyte DNA synthetic response after partial hepatectomy. It provides the first in vivo evidence that STAT3 promotes cell cycle progression under physiological growth conditions.
Key findings
- STAT3 deletion was efficient: more than 90% deletion of the STAT3 gene, with virtually no STAT3 mRNA, nuclear protein, or DNA binding activity in Alb+STAT3fl/fl livers after partial hepatectomy.
- Hepatocyte DNA synthesis at 40 h posthepatectomy in Alb+STAT3fl/fl livers was reduced to approximately one-third of control (a 3-fold difference, p < 0.02), with reduced DNA synthesis at other time points; liver mass was nonetheless regained normally after 1 week with no sign of injury.
- In the absence of STAT3, STAT1 was activated instead: a high level of a complex migrating at the STAT1 homodimer position appeared posthepatectomy, confirmed by supershift with anti-STAT1 but not anti-STAT3 antibody, and nuclear STAT1 protein was markedly induced.
- Immediate-early gene activation was abnormal but not identical to IL-6−/− livers: c-fos and junB were significantly reduced at all time points, c-myc peak activation was delayed, IGFBP-1 was reduced 2-fold at 2 h (vs. more than 3-fold in IL-6−/−), and Egr-1 was up-regulated rather than down-regulated. Of 10 STAT3 target genes, only 1 (lymphotoxin receptor) had not previously been identified as an IL-6 target.
- G1 phase cyclins were partially impaired: cyclin D1 was normal early but reduced at the peak of DNA synthesis (40 h) and remained low; cyclin E induction was delayed until 32 h (vs. 16 h in controls) and lower at later time points.
- MAPK activation followed the same kinetics as controls with no consistent or significant difference in phosphorylated Erk1 or Erk2 at any time point, supporting STAT3 and MAPK as independent IL-6 signaling pathways.
Methods
- Liver-specific STAT3 conditional knockout: STAT3fl/fl mice crossed to albumin promoter–driven Cre transgenic mice to generate Alb+STAT3fl/fl mice and Alb−STAT3fl/fl littermate controls; F1 progeny used in all experiments.
- 8–12-week-old mice underwent two-thirds partial hepatectomy (left lateral and median lobes removed) and were sacrificed at various time points; BrdUrd immunohistochemistry quantified labeled hepatocyte nuclei in 12 random 20× fields (~200 cells/field).
- Analyses included Northern blot, Western blot of whole and nuclear liver extracts, electrophoretic mobility shift assay with supershift, cDNA microarray of RNA at 2 h posthepatectomy, and serum index testing.
Limitations
- Stated by the paper: whether STAT1 can substitute for STAT3 in binding HNF-1 requires further analysis; it is unknown whether cyclin E is regulated by IL-6 during liver regeneration because cyclin E expression was not examined in IL-6−/− livers; other IL-6-activated signaling pathways important for normal liver cell function during regrowth await characterization.
- Evident from the text: the microarray comparison was performed at a single time point (2 h posthepatectomy), and the mechanism by which STAT3 normally inhibits STAT1 activation is described as unknown.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
18 of 68 cited sources checked · 8 supported · 1 flagged · accuracy not yet measured
- Findingcitation§ RESULTS
Three IL-6 target genes did not show IL-6 regulation posthepatectomy but were activated by IL-6 injection in the liver (TDAG51, membrane glycoprotein gp130, and Erp72).
“Three did not show IL-6 regulation posthepatectomy but were activated by IL-6 injection in the liver (TDAG51, membrane glycoproteingp130, and Erp72, the endoplasmic reticulum stress protein) (4”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [4] Li, 2001, Hepatology source
Table 1 (HEPATOLOGY June 2001 section; page not supplied) lists ERp72, gp130, and TDAG51 with differential expression between IL-6-positive and IL-6-deficient livers two hours after hepatectomy. That is contrary to the claim that these three showed no IL-6 regulation posthepatectomy. The table passage does not clearly establish the claimed injection result for all three. (LLM, conf=0.82)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
- Premisecitation§ Abstract
STAT3 is rapidly induced during liver regeneration in an IL-6-dependent fashion.
“STAT3 is rapidly induced during liver regeneration in an interleukin 6 (IL-6)-dependent fashion, and IL-6 is required for normal liver regeneration.”
Quote in the paperSubstantial claim1 of 2 sources checked - Premisecitation§ Abstract
IL-6 is required for normal liver regeneration.
“STAT3 is rapidly induced during liver regeneration in an interleukin 6 (IL-6)-dependent fashion, and IL-6 is required for normal liver regeneration.”
Quote in the paperSubstantial claim1 of 2 sources checked - Premisecitation§ Abstract
IL-6−/− mice have impaired liver regeneration characterized by liver necrosis and failure.
“IL-6−/− mice have impaired liver regeneration characterized by liver necrosis and failure, a blunted DNA synthetic response in hepatocytes, and reduced gene activation during G1 phase.”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [3] Cressman, 1996, Science source
- cites [4] Li, 2001, Hepatology source
The introductory passage following the Abstract says IL-6-deficient mice have impaired regeneration and liver necrosis after 70% partial hepatectomy. It says they are prone to liver failure, rather than stating that liver failure occurs in all such mice; the claim omits that qualification. (LLM, conf=0.83)
Experimental — accuracy not yet measured
- Premisecitation§ Abstract
IL-6−/− mice have reduced gene activation during G1 phase.
“IL-6−/− mice have impaired liver regeneration characterized by liver necrosis and failure, a blunted DNA synthetic response in hepatocytes, and reduced gene activation during G1 phase.”
Quote in the paperSubstantial claim1 of 2 sources checked
- Premisecitation§ Abstract
IL-6 also activates other signaling pathways including the MAPK pathway during liver regeneration.
“However, because IL-6 also activates other signaling pathways including the mitogen-activated protein kinase (MAPK) pathway during liver regeneration (4”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [4] Li, 2001, Hepatology source
- Premisecitation§ Abstract
IL-6 is one of the most important initiators of the regenerative response.
“Interleukin-6 (IL-6)1 is known as one of the most important initiators of the regenerative response (3”
Quote in the paperSubstantial claim1 of 2 sources checked - Premisecitation§ Abstract
IL-6−/− mice have a blunted DNA synthetic response in hepatocytes.
“IL-6−/− mice have impaired liver regeneration characterized by liver necrosis and failure, a blunted DNA synthetic response in hepatocytes, and reduced gene activation during G1 phase.”
Quote in the paperSubstantial claim1 of 2 sources checked - Interpretationcitation§ DISCUSSION
c-fos and junB expression is likely to be directly regulated by STAT3 because their full transactivation requires the STAT binding elements in their promoters.
“their expression is likely to be directly regulated by STAT3 because their full transactivation requires the STAT binding elements in their promoters (19”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [19] Wagner, 1990, EMBO J. source
The c-fos promoter experiments (section labeled Introduction; page unavailable) show that a SIF-binding element enhances c-sis/PDGF-induced transcription and that nonbinding mutations abolish induction in the tested constructs. The paper does not address junB or identify SIF as STAT3, and these experiments do not establish that STAT binding elements are required for full transactivation of both genes. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites [27] Coffer, 1995, Oncogene
- Premisecitation§ Abstract
In IL-6−/− livers, the first peak of MAPK activation is delayed until 12 h compared with 2 h posthepatectomy in IL-6+/+ livers.
“In IL-6−/− livers, the first peak of MAPK activation is delayed until 12 h compared with 2 h posthepatectomy in IL-6+/+ livers”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [4] Li, 2001, Hepatology source
- Findingown data§ RESULTS
Only 1 of 10 STAT3 target genes had not previously been identified as an IL-6 target gene (lymphotoxin receptor).
“Only 1 of 10 STAT3 target genes had not previously been identified as an IL-6 target gene (lymphotoxin receptor).”
Quote in the paperSubstantial claim - Findingown data§ Abstract
Unlike control livers, STAT1 is activated in STAT3 conditional-mutant livers posthepatectomy.
“Unlike in control livers, STAT1 was activated in STAT3 conditional-mutant livers posthepatectomy.”
Quote in the paperNot a substantial claim - Findingown data§ RESULTS
The degree of overlap between the two gene sets was high.
“However, the degree of overlap between the two gene sets was high.”
Quote in the paperSubstantial claim - Findingown data§ Abstract
STAT3 DNA binding activity is absent in Alb+STAT3fl/fl livers after partial hepatectomy.
“STAT3 DNA binding activity was also absent in Alb+ STAT3fl/fllivers.”
Quote in the paperSubstantial claim - Findingown data§ Abstract
STAT3 regulates the expression of some IL-6 target genes during liver regeneration.
“STAT3 regulates the expression of some IL-6 target genes during liver regeneration but could not account for all of the gene expression abnormalities observed in IL-6−/− livers.”
Quote in the paperSubstantial claim - Findingown data§ RESULTS
There was no significant difference in serum indexes from Alb+ compared with Alb−STAT3fl/fl livers.
“There was no significant difference in the serum indexes from the Alb+ compared with the Alb−STAT3fl/fl livers”
Quote in the paperNot a substantial claim - Findingown data§ Abstract
DNA synthesis is partially impaired in Alb+STAT3fl/fl livers.
“We found that DNA synthesis was partially impaired in Alb+ STAT3fl/fl livers but that liver regeneration still occurred in the absence of STAT3.”
Quote in the paperSubstantial claim - Findingown data§ Abstract
Liver regeneration still occurs in the absence of STAT3.
“We found that DNA synthesis was partially impaired in Alb+ STAT3fl/fl livers but that liver regeneration still occurred in the absence of STAT3.”
Quote in the paperSubstantial claim - Findingown data§ RESULTS
There was more than 90% deletion of the STAT3 gene in Alb+STAT3fl/fl livers.
“We estimated that there was more than 90% deletion of the STAT3 gene.”
Quote in the paperSubstantial claim - Findingown data§ RESULTS
MAPK activation in Alb+STAT3fl/fl livers follows the same kinetics as control livers.
“The activation of MAPK in Alb+ STAT3fl/fl livers followed the same kinetics as found in control livers.”
Quote in the paperSubstantial claim - Findingown data§ Abstract
Alb+STAT3fl/fl livers have abnormalities in immediate-early gene activation that largely correlate with but are not identical to those seen in IL-6−/− livers.
“Alb+STAT3fl/fl livers had abnormalities in immediate-early gene activation that largely correlated with but were not identical to those seen in IL-6−/− livers.”
Quote in the paperSubstantial claim - Findingown data§ Abstract
G1 phase cyclins including cyclins D1 and E have lower expression levels in Alb+STAT3fl/fl livers.
“G1 phase cyclins including cyclins D1 and E had lower expression levels in Alb+ STAT3fl/fl livers, indicating an abnormal G1 to S phase transition.”
Quote in the paperSubstantial claim - Findingown data§ RESULTS
c-fos and junB expression were significantly reduced in Alb+STAT3fl/fl livers at all time points compared with Alb−STAT3fl/fl livers.
“As in IL-6−/− livers, c-fos, and junB expression were significantly reduced in Alb+STAT3fl/fl livers at all time points compared with Alb− STAT3fl/fl livers.”
Quote in the paperSubstantial claim - Findingown data§ RESULTS
A smaller number of immediate-early genes were differentially expressed in Alb−STAT3fl/fl livers versus Alb+STAT3fl/fl livers compared with those differentially expressed in IL-6+/+ and −/− livers.
“A smaller number of immediate-early genes were differentially expressed in Alb− STAT3fl/fl liversversus Alb+ STAT3fl/fllivers compared with those differentially expressed in the IL-6+/+ and −/− livers.”
Quote in the paperSubstantial claim - Findingown data§ RESULTS
MAPK pathway activation is normal in Alb+STAT3fl/fl livers posthepatectomy.
“The activation of MAPK in Alb+ STAT3fl/fl livers followed the same kinetics as found in control livers.”
Quote in the paperSubstantial claim - Findingown data§ RESULTS
STAT3 mRNA is present in quiescent Alb−STAT3fl/fl liver but not in Alb+STAT3fl/fl livers.
“STAT3 mRNA was present in the quiescent Alb−STAT3fl/fl liver but not in Alb+STAT3fl/fl livers.”
Quote in the paperSubstantial claim - Findingown data§ Abstract
After partial hepatectomy, there is virtually no STAT3 RNA or protein induction in Alb+STAT3fl/fl livers.
“After partial hepatectomy, there was virtually no STAT3 RNA or protein induction in Alb+STAT3fl/fl livers.”
Quote in the paperSubstantial claim - Findingown data§ Abstract
STAT3 could not account for all of the gene expression abnormalities observed in IL-6−/− livers.
“STAT3 regulates the expression of some IL-6 target genes during liver regeneration but could not account for all of the gene expression abnormalities observed in IL-6−/− livers.”
Quote in the paperSubstantial claim - Findingown data§ RESULTS
No consistent or significant difference in the level of phosphorylated Erk1 or phosphorylated Erk2 was observed at any time point.
“After quantification using scanning densitometry, no consistent or significant difference in the level of either the phosphorylated Erk1 or the phosphorylated Erk2 was observed at any time point.”
Quote in the paperSubstantial claim - Findingown data§ RESULTS
The most prominent form of the DNA binding complex in control livers is the STAT3/STAT3 homodimer.
“The most prominent form of the DNA binding complex was the STAT3/STAT3 homodimer.”
Quote in the paperNot a substantial claim - Findingown data§ RESULTS
There is no detectable STAT3 protein in Alb+STAT3fl/fl livers.
“In contrast, there was no detectable STAT3 protein in Alb+STAT3fl/fl livers.”
Quote in the paperSubstantial claim - Findingown data§ RESULTS
Egr-1, which was down-regulated in IL-6−/− livers 2 h posthepatectomy, was up-regulated in Alb+STAT3fl/fl livers.
“Interestingly, Egr-1, which was down-regulated in IL-6−/− livers 2 h posthepatectomy, was up-regulated in Alb+ STAT3fl/fllivers”
Quote in the paperNot a substantial claim - Findingown data§ RESULTS
Peak activation of c-myc was delayed in Alb+STAT3fl/fl livers compared with Alb−STAT3fl/fl livers.
“Peak activation of c-myc was delayed in Alb+STAT3fl/fl livers compared with Alb− STAT3fl/fl livers.”
Quote in the paperSubstantial claim - Findingcitation§ RESULTS
Of the nine IL-6 target genes, six were differentially expressed in the IL-6+/+ and −/− livers posthepatectomy, including c-myc, TNFR2, GADD-45, serine protease inhibitor 2.4, c-fos, and Egr-1.
“Of the nine IL-6 target genes, six were differentially expressed in the IL-6+/+ and −/− livers posthepatectomy, including c-myc, TNFR2, GADD-45, serine protease inhibitor 2.4, c-fos, and Egr-1.”
Quote in the paperSubstantial claim - Findingown data§ Abstract
Hepatocyte DNA synthesis at 40 h posthepatectomy in Alb+STAT3fl/fl livers is reduced to approximately one-third of control.
“Hepatocyte DNA synthesis at 40 h posthepatectomy in Alb+STAT3fl/fl livers was reduced to approximately one-third of the control.”
- Also stated in: § RESULTS · plain
“There was a 3-fold difference in the number of hepatocytes undergoing DNA synthesis at 40 h posthepatectomy (p < 0.02) and reduced DNA synthesis at other time points (Fig. 3, A andB)”
Quote in the paperSubstantial claim - Also stated in: § RESULTS · plain
- Findingown data§ RESULTS
Peak STAT3 DNA binding occurs at 2 h posthepatectomy in control livers.
“Peak STAT3 DNA binding occurred at 2 h posthepatectomy in control livers.”
Quote in the paperNot a substantial claim - Findingnone given§ DISCUSSION
STAT3 was necessary for the activation of G1 phase cyclins that support DNA synthesis and mitosis.
“STAT3 was also necessary for the activation of G1 phase cyclins that support DNA synthesis and mitosis.”
Quote in the paperSubstantial claim - Findingreasoning§ Abstract
In the STAT3 conditional knock-out, the spectrum of genes with reduced expression is smaller than that seen in the IL-6 knock-out.
“In the STAT3 conditional knock-out, we observed that the spectrum of genes in which expression levels are reduced is smaller compared with that seen in the IL-6 knock-out.”
Quote in the paperSubstantial claim - Findingown data§ Abstract
In the absence of STAT3, STAT1 activation was dramatically increased posthepatectomy.
“In the absence of STAT3, STAT1 activation was dramatically increased posthepatectomy”
Quote in the paperSubstantial claim - Findingcitation§ RESULTS
The change in IGFBP-1 expression in STAT3 conditional-mutant livers is not as great as that seen in IL-6−/− livers.
“However, the change is not as great as that seen in the IL-6−/− livers (5”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [5] Leu, 2001, Mol. Cell. Biol. source
- Findingown data§ RESULTS
c-Fos protein induction is delayed in Alb+STAT3fl/fl livers (little induction until 4 h posthepatectomy) compared with Alb−STAT3fl/fl livers, in which induction is detected as early as 1 h and peaks at 2 h posthepatectomy.
“In Alb−STAT3fl/fl livers, induction of c-Fos was detected as early as 1 h, and there was a peak induction at 2 h posthepatectomy. There was little induction of c-Fos until 4 h posthepatectomy in Alb+ STAT3fl/fllivers.”
Quote in the paperSubstantial claim - Findingown data§ RESULTS
STAT1 DNA binding activity is increased in Alb+STAT3fl/fl livers posthepatectomy.
“This result correlated with the increased STAT1 DNA binding activity in Alb+ STAT3fl/fl livers posthepatectomy.”
Quote in the paperNot a substantial claim - Findingcitation§ RESULTS
In STAT3 conditional-mutant livers, IGFBP-1 expression is reduced at 2 h posthepatectomy by 2-fold based on three different sets of samples.
“In STAT3 conditional-mutant livers,IGFBP-1 expression is reduced at 2 h posthepatectomy by 2-fold based on the result of three different sets of samples.”
Quote in the paperNot a substantial claim - Findingreasoning§ DISCUSSION
c-fos and junB are the most strongly affected immediate-early genes in IL-6−/− livers.
“These two genes are the most strongly affected immediate-early genes in IL-6−/− livers”
Quote in the paperNot a substantial claim - Findingreasoning§ DISCUSSION
STAT3 was required for the activation of several immediate-early genes at the gene expression level, including c-fos and junB.
“STAT3 was required for the activation of several immediate-early genes at the gene expression level including c-fos and junB.”
Quote in the paperSubstantial claim - Findingreasoning§ DISCUSSION
DNA synthesis posthepatectomy was partially impaired in the absence of STAT3.
“DNA synthesis posthepatectomy was partially impaired in the absence of STAT3”
Quote in the paperSubstantial claim - Findingown data§ Abstract
At the peak of S phase (approximately 40 h posthepatectomy in mouse livers), the percentage of hepatocytes undergoing DNA synthesis is 5-fold lower in IL-6−/− livers than in IL-6+/+ livers.
“at the peak of S phase, which is approximately 40 h posthepatectomy in mouse livers, the percentage of hepatocytes undergoing DNA synthesis is 5-fold lower in IL-6−/− livers than IL-6+/+ livers”
Quote in the paperSubstantial claim - Findingown data§ Abstract
At the peak of S phase, the difference in DNA synthesis between Alb+ and Alb−STAT3fl/fl livers is about 3-fold.
“whereas the difference between the Alb+ and Alb− STAT3fl/fl livers is smaller at about 3-fold.”
Quote in the paperSubstantial claim - Findingown data§ Abstract
MAPK activation is normal in Alb+STAT3fl/fl livers during the early time points posthepatectomy.
“In contrast, MAPK activation is normal in Alb+STAT3fl/fl livers during the early time points posthepatectomy”
Quote in the paperSubstantial claim - Interpretationown data§ Abstract
Normal activation of the MAPK pathway in Alb+STAT3fl/fl livers reinforces that at least part of the effect of IL-6 on hepatocyte proliferation is not mediated by STAT3.
“Normal activation of the MAPK pathway in Alb+STAT3fl/fl livers reinforces the fact that at least part of the effect of IL-6 on hepatocyte proliferation is not mediated by STAT3.”
Quote in the paperSubstantial claim - Interpretationown data§ Abstract
STAT3 promotes cell cycle progression and cell proliferation by up-regulating immediate-early growth response genes.
“This is the first in vivo evidence that STAT3 promotes cell cycle progression and cell proliferation by up-regulating immediate-early growth response genes.”
Quote in the paperSubstantial claim- Rests on an assumption: The immediate-early gene expression changes at 2 h posthepatectomy are causally responsible for the subsequent hepatocyte DNA synthesis at 40 h.
- Premisecitation§ RESULTS
In IL-6−/− livers, abnormalities in the induction and temporal expression of several important immediate-early growth response genes are observed posthepatectomy.
“In IL-6−/− livers, abnormalities in the induction and temporal expression of several important immediate-early growth response genes are observed posthepatectomy (3”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] Cressman, 1996, Science source
- Interpretationcitation§ Abstract
The absence of STAT3 activation posthepatectomy in IL-6−/− livers supports a possible pro-proliferative role of STAT3 in hepatocytes.
“Furthermore, STAT3 activation is absent posthepatectomy in IL-6−/− livers, which supports a possible pro-proliferative role of STAT3 in hepatocytes (3”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] Cressman, 1996, Science source
- Premisecitation§ Abstract
STAT3 activation is absent posthepatectomy in IL-6−/− livers.
“Furthermore, STAT3 activation is absent posthepatectomy in IL-6−/− livers, which supports a possible pro-proliferative role of STAT3 in hepatocytes (3”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] Cressman, 1996, Science source
- Interpretationown data§ RESULTS
Egr-1 activation posthepatectomy is STAT3-independent.
“indicating a STAT3-independent activation of Egr-1posthepatectomy.”
Quote in the paperNot a substantial claim - Interpretationown data§ Abstract
STAT3 accounts for part of the DNA synthetic response of hepatocytes during liver regeneration.
“Therefore, STAT3 accounts for part of the DNA synthetic response of the hepatocytes during liver regeneration, which cannot be compensated for by induction of STAT1.”
Quote in the paperSubstantial claim- Rests on an assumption: The STAT3 conditional deletion in the liver is specific to hepatocytes and does not affect other liver cell types.
- Interpretationown data§ RESULTS
STAT3 and MAPK represent two independent IL-6 signaling pathways.
“This finding supports the conclusion that STAT3 and MAPK represent two independent IL-6 signaling pathways.”
Quote in the paperSubstantial claim - Study design and conductown data§ RESULTS
The disruption of the STAT3 gene by Cre recombinase in the liver is efficient.
“These results proved that the disruption of STAT3 gene by Cre recombinase in the liver is efficient.”
Quote in the paperSubstantial claim - Study design and conductown data§ RESULTS
Supershift assay confirmed the composition of the DNA binding complexes in both Alb− and Alb+ STAT3fl/fl livers.
“Supershift assay was used to confirm the composition of the DNA binding complexes in both the Alb− and Alb+ STAT3fl/fl livers (Fig.2 B).”
Quote in the paperSubstantial claim - Interpretationown data§ Abstract
This study provides the first in vivo evidence that STAT3 promotes cell cycle progression and cell proliferation under physiological growth conditions.
“This study provides the first in vivoevidence that STAT3 promotes cell cycle progression and cell proliferation under physiological growth conditions.”
Quote in the paperSubstantial claim- Rests on an assumption: The immediate-early gene expression changes at 2 h posthepatectomy are causally responsible for the subsequent hepatocyte DNA synthesis at 40 h.
- Premisecitation§ Abstract
Conditional deletion of STAT3 in the liver demonstrated that STAT3 is essential for the induction of all acute phase response genes downstream of IL-6.
“Also the conditional deletion of STAT3 in the liver demonstrated that STAT3 is essential for the induction of all acute phase response genes downstream of IL-6 (14”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] Alonzi, 2001, Mol. Cell. Biol. source
- Interpretationown data§ Abstract
The part of the DNA synthetic response accounted for by STAT3 cannot be compensated for by induction of STAT1.
“Therefore, STAT3 accounts for part of the DNA synthetic response of the hepatocytes during liver regeneration, which cannot be compensated for by induction of STAT1.”
Quote in the paperSubstantial claim- Rests on an assumption: The STAT1 DNA binding activity observed in Alb+STAT3fl/fl livers represents functional STAT1 signaling capable of compensating for STAT3 loss.
- Interpretationown data§ Abstract
The lower expression of G1 phase cyclins in Alb+STAT3fl/fl livers indicates an abnormal G1 to S phase transition.
“G1 phase cyclins including cyclins D1 and E had lower expression levels in Alb+ STAT3fl/fl livers, indicating an abnormal G1 to S phase transition.”
Quote in the paperSubstantial claim - Interpretationown data§ Abstract
STAT1 activation was not sufficient to compensate for all STAT3 function, because disruption of STAT3 still led to down-regulation of several immediate-early genes at a level comparable to that seen in the IL-6 knock-outs.
“However, STAT1 activation was not sufficient to compensate for all STAT3 function because disruption of STAT3 still led to down-regulation of several immediate-early genes, and the level of the reduction was comparable with that seen in the IL-6 knock-outs.”
Quote in the paperSubstantial claim - Premisecitation§ RESULTS
IGFBP-1 activation is in part regulated by IL-6 via direct interaction between STAT3, AP-1, and HNF-1 transcription factors.
“Its activation is in part regulated by IL-6 via direct interaction between STAT3, AP-1, and HNF-1 transcription factors (5”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [5] Leu, 2001, Mol. Cell. Biol. source
- Premisecitation§ Abstract
Activation of the MAPK pathway is a key signal for the G1 phase progression of proliferating hepatocytes after partial hepatectomy.
“It was demonstrated clearly that activation of the MAPK pathway is a key signal for the G1 phase progression of the proliferating hepatocytes after partial hepatectomy (47”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [47] Talarmin, 1999, Mol. Cell. Biol. source
- Premisecitation§ Abstract
All of the other STAT knock-outs have relatively mild phenotypes correlated with rather specific defects in response to certain cytokines or growth factors.
“All of the other STAT knock-outs have relatively mild phenotypes correlated with rather specific defects in response to certain cytokines or growth factors (12”
Quote in the paperSubstantial claim0 of 5 sources checked - Interpretationown data§ Abstract
Normally STAT3 may inhibit STAT1 activation during liver regeneration by unknown mechanisms.
“suggesting that normally STAT3 may inhibit STAT1 activation during liver regeneration by unknown mechanisms.”
Quote in the paperNot a substantial claim - Interpretationreasoning§ Abstract
IGFBP-1 represents a class of STAT3 target genes whose expression may be partially rescued in the presence of STAT1.
“It represents a class of STAT3 target genes for which expression may be rescued partially in the presence of STAT1”
Quote in the paperSubstantial claim - Premisecitation§ Abstract
STAT1 is the only STAT in addition to STAT3 that is activated during liver regeneration.
“STAT1 is the only STAT in addition to STAT3 that is activated during liver regeneration (17”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [17] Cressman, 1995, Hepatology source
- Interpretationown data§ DISCUSSION
The results obtained from Alb+STAT3fl/fl represent the first example of a pro-proliferative role of STAT3 under physiological growth conditions in vivo.
“The results obtained from Alb+STAT3fl/fl are important because they represent the first example of a pro-proliferative role of STAT3 under physiological growth conditions in vivo.”
Quote in the paperSubstantial claim - Premiseown data§ Abstract
IGFBP-1 expression is activated by STAT3 in coordination with AP-1 and HNF-1 transcription factors via an HNF-1 binding site during liver regeneration.
“The expression of IGFBP-1 is activated by STAT3 in coordination with AP-1 and HNF-1 transcription factors via an HNF-1 binding site during liver regeneration.”
Quote in the paperSubstantial claim - Interpretationown data§ DISCUSSION
The study reported here is the first in vivo evidence that STAT3 can directly participate in cell cycle progression.
“The study reported here is the first in vivo evidence that STAT3 can directly participate in cell cycle progression.”
Quote in the paperSubstantial claim - Interpretationown data§ Abstract
IL-6 activation of the MAPK pathway is independent of STAT3 activation.
“suggesting that IL-6 activation of the MAPK pathway is independent of STAT3 activation.”
Quote in the paperSubstantial claim - Premisecitation§ Abstract
A certain percentage of IL-6−/− animals die after surgery because of liver necrosis and failure.
“A certain percentage of IL-6−/− animals die after surgery because of liver necrosis and failure (3”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] Cressman, 1996, Science source
- Interpretationreasoning§ Abstract
The STAT3 effect on hepatocyte DNA synthesis and cell proliferation is not secondary to direct effects on the MAPK pathway.
“it also suggests that the STAT3 effect on hepatocyte DNA synthesis and cell proliferation is not secondary to direct effects on the MAPK pathway.”
Quote in the paperSubstantial claim
- Classified as probably not a substantial claim. 14
- May combine two claims. 21
- The quote only partly states this claim. 1
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ AbstractSpecific disruption of STAT3 in T cells revealed that STAT3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis.
“Specific disruption of STAT3 in T cells revealed that STAT3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis (13”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [13] Takeda, 1998, J. Immunol. source
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DISCUSSIONA number of transformed cell lines as well as samples from human cancers are reported to contain constitutively activated STAT3.
“A number of transformed cell lines as well as samples from human cancers are reported to contain constitutively activated STAT3.”
Quote in the paperNot a substantial claim2 of 6 sources checked- cites [20] Yu, 1995, Science source
- cites [21] Cao, 1996, Mol. Cell. Biol. source
The Abstract (p. 1595) reports constitutively activated Stat3 in all v-Src-transformed cell lines examined. Our copy does not report the same finding in samples from human cancers, so that part of the claim is unsupported. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [22] Turkson, 2000, Oncogene source
- cites [23] Danial, 1995, Science source
- cites [24] Nielsen, 1997, Proc. Natl. Acad. Sci. U. S. A. source
- cites [25] Gouilleux-Gruart, 1996, Blood source
The Results report constitutive DNA-binding by a STAT3-related factor in several patients’ AML samples, supporting the human-cancer-sample part of the claim. The Discussion also cites STAT3-related activity in Src-transformed cells, but it does not establish constitutively activated STAT3 in a number of transformed cell lines; it notes that the factor detected in AML may differ from STAT3. The indexed passages provide no page numbers. (LLM, conf=0.84)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisecitation§ DISCUSSIONThe STAT family consists of seven members that in vitro bind a similar consensus DNA element, TTCnnn(n)GAA.
“The STAT family consists of seven family members, and in vitro they bind to a similar consensus element on the DNA, TTCnnn(n)GAA (31-33”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [31] Schindler, 1995, Immunity source
- cites [32] Schindler, 1995, Annu. Rev. Biochem. source
- cites [33] Seidel, 1995, Proc. Natl. Acad. Sci. U. S. A. source
The indexed passage on STAT-binding elements (Abstract, p. 3041) supports binding to a broadly similar palindromic DNA element, describing a general TT(N)5AA structure and testing different half-site spacings. It does not state that the STAT family has seven members, or establish the exact TTCnnn(n)GAA consensus given in the claim. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ AbstractAlthough STATs bind a similar DNA binding site, they may interact with co-activators or co-repressors to regulate different sets of their own downstream targets.
“Although they bind to a similar DNA binding site, STATs may interact with co-activator or co-repressor to regulate different sets of their own downstream targets (5”
Quote in the paperNot a substantial claim3 of 8 sources checked- cites [5] Leu, 2001, Mol. Cell. Biol. source
- cites [38] Look, 1995, J. Biol. Chem. source
- cites [39] Ohmori, 1997, J. Biol. Chem. source
- cites [40] Schaefer, 1995, Proc. Natl. Acad. Sci. U. S. A. source
The Discussion (page not provided) reports cooperative activation of a promoter by Stat3β and c-Jun and suggests this could matter for responses involving other STAT proteins. It does not establish that STATs generally bind similar DNA sites or interact with co-repressors to regulate different sets of downstream targets. The similar-site discussion in the introduction concerns Jun and Fos proteins, not STATs. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [41] Ichiba, 1998, J. Biol. Chem. source
- cites [42] Stocklin, 1996, Nature source
The paper reports that the glucocorticoid receptor acts as a co-activator for Stat5 and proposes that different co-activators could contribute to signaling specificity. It does not establish that STAT family members bind similar DNA sites or interact with co-repressors to regulate distinct sets of downstream targets (section “Functional interactions between Stat5 and the glucocorticoid receptor”; page unavailable in our copy). (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [43] Mikita, 1998, J. Immunol. source
The Discussion (page unavailable) says STAT proteins can cooperate with other transcription factors and that the interactions probably depend on promoter context; it demonstrates Stat6–C/EBPβ synergy at one promoter. It does not establish that different STATs bind similar DNA sites or that co-repressors help them regulate distinct sets of downstream targets. (LLM, conf=0.83)
Experimental — accuracy not yet measured - cites [44] Bhattacharya, 1996, Nature source
May combine two claims.
Premisecitation§ DISCUSSIONRegaining liver mass despite deficient DNA synthesis is a general phenomenon in animal models defective in liver regeneration, most likely resulting from hypertrophy of hepatocytes despite G1/S arrest.
“Regaining liver mass despite deficient DNA synthesis is a general phenomenon in animal models that are defective in liver regeneration, which most likely results from hypertrophy of hepatocytes despite G1/S arrest (3”
Quote in the paperNot a substantial claim1 of 5 sources checked- cites [3] Cressman, 1996, Science source
- cites [18] Greenbaum, 1998, J. Clin. Invest. source
The Results report markedly reduced DNA synthesis in C/EBPβ-deficient mice without a statistically significant difference in liver-mass reconstitution. The Discussion proposes increased cell size during G1 as an explanation and suggests that the cell-cycle block may occur near G1/S. It does not establish this as a general phenomenon across animal models or demonstrate hepatocyte hypertrophy despite a confirmed G1/S arrest. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [28] Cornell, 1990, Hepatology source
- cites [29] Roselli, 1998, Am. J. Physiol.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [30] Yamada, 1997, Proc. Natl. Acad. Sci. U. S. A. source
May combine two claims.
Findingown data§ RESULTSIn Alb+STAT3fl/fl livers after surgery, there is little STAT3/STAT3 homodimer but a high level of complex migrating at the position of the STAT1 homodimer.
“In contrast, there was little STAT3/STAT3 homodimer observed in Alb+STAT3fl/fl livers after surgery, but a high level of complex was detected migrating at the position of the STAT1 homodimer.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ RESULTSMore than 100 immediate-early genes are activated at 2 h posthepatectomy, 36% of which also showed IL-6 regulation posthepatectomy.
“By using a mouse cDNA expression array, we successfully identified more than 100 immediate-early genes that are activated at 2 h posthepatectomy, 36% of which also showed IL-6 regulation posthepatectomy.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ RESULTSThere was a 3-fold difference in the number of hepatocytes undergoing DNA synthesis at 40 h posthepatectomy (p < 0.02) and reduced DNA synthesis at other time points.
“There was a 3-fold difference in the number of hepatocytes undergoing DNA synthesis at 40 h posthepatectomy (p < 0.02) and reduced DNA synthesis at other time points (Fig. 3, A andB)”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ RESULTSSTAT3 protein is not present in the nucleus in quiescent livers, but its level rises rapidly and peaks around 2 h posthepatectomy in Alb−STAT3fl/fl livers.
“STAT3 was not present in the nucleus in quiescent livers, but the level went up rapidly and peaked around 2 h posthepatectomy in Alb−STAT3fl/fl livers (Fig. 1 B).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ RESULTSAlb+STAT3fl/fl animals regained liver mass normally after 1 week of surgery showing no sign of injury at any time point posthepatectomy.
“Alb+STAT3fl/fl animals regained liver mass normally after 1 week of surgery showing no sign of injury at any time point posthepatectomy (data not shown).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ RESULTSIn control livers, STAT3 mRNA is rapidly induced after surgery and remains high until 24 h posthepatectomy, whereas there is only minimum induction in Alb+STAT3fl/fl livers.
“In control livers, the message was rapidly induced after surgery and remained high until 24 h posthepatectomy, whereas there was only minimum induction of the STAT3 mRNA in Alb+STAT3fl/fl livers (Fig.1 A).”
Quote in the paperSubstantial claimMay combine two claims. The quote only partly states this claim.
Findingown data§ RESULTSAlb+STAT3fl/fl mice are viable and fertile, have no developmental abnormalities, and the gross morphology of the liver is normal.
“Alb+STAT3fl/fl mice are fertile, they have no developmental abnormalities, and the gross morphology of the liver is also normal.”
Quote in the paperSubstantial claimMay combine two claims.
Findingcitation§ RESULTSA low level of STAT3/STAT1 heterodimer and an even lower level of STAT1 homodimer are observed in control livers.
“A low level of STAT3/STAT1 heterodimer as well as an even lower level of STAT1 homodimer band were also observed as we have reported previously (17”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [17] Cressman, 1995, Hepatology source
May combine two claims.
Findingown data§ RESULTSIn Alb+STAT3fl/fl livers, the putative STAT1/STAT1 homodimer was disrupted by α-STAT1 antibody, and α-STAT3 antibody had no effect.
“but the putative STAT1/STAT1 homodimer in Alb+STAT3fl/fl livers was disrupted by the α-STAT1 antibody. α-STAT3 antibody had no effect on this complex.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ RESULTSIn control livers, the main DNA binding band was supershifted by α-STAT3 antibody, and anti-STAT1 antibody had no effect.
“When preincubated with α-STAT3 antibody, the main DNA binding band in Alb− STAT3fl/fllivers was supershifted, and multiple supershift complexes were formed. Anti-STAT1 antibody had no effect on this complex”
Quote in the paperSubstantial claimMay combine two claims.
Findingcitation§ DISCUSSIONLiver mass restoration occurred in the absence of STAT3 as it does in IL-6−/− livers.
“although mass restoration occurred as in IL-6−/− livers (3”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] Cressman, 1996, Science source
May combine two claims.
Findingown data§ RESULTSCyclin D1 expression is normal at earlier time points during the cell cycle but is reduced at the peak of DNA synthesis (40 h posthepatectomy) and remains low at all later time points in Alb+ compared with Alb−STAT3fl/fl livers.
“Cyclin D1 expression was normal at earlier time points during the cell cycle but was reduced at the peak of DNA synthesis (40 h posthepatectomy) and remained low at all later time points in the Alb+ compared with Alb−STAT3fl/fl livers.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ AbstractIGFBP-1 expression level is 2-fold lower in Alb+STAT3fl/fl livers than control livers, compared with more than 3-fold lower in IL-6−/− livers.
“Its expression level is 2-fold lower in Alb+ STAT3fl/fl livers than control livers compared with more than 3-fold lower in IL-6−/− livers.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ RESULTSEgr-1 is expressed at a lower level at 2 h posthepatectomy in IL-6−/− livers but at a higher level at all time points in Alb+STAT3fl/fl livers compared with Alb−STAT3fl/fl livers.
“Interestingly, Egr-1 is expressed at a lower level at 2 h posthepatectomy in IL-6−/− livers but a higher level at all time points in Alb+STAT3fl/fl livers compared with Alb− STAT3fl/fl livers.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ RESULTSThe STAT1 protein level is markedly induced in the nucleus of Alb+STAT3fl/fl livers posthepatectomy, whereas control livers show only a slight increase.
“The STAT1 protein level was markedly induced in the nucleus of Alb+STAT3fl/fl livers, whereas in control livers there was only a slight increase in the STAT1 level posthepatectomy.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingnone given§ AbstractAlb+STAT3fl/fl animals were viable after hepatectomy with no signs of liver injury.
“whereas Alb+STAT3fl/fl animals were viable after hepatectomy with no signs of liver injury.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ AbstractDisruption of the STAT3 gene during embryonic stages causes lethality.
“Because STAT3 deletion leads to embryonic lethality (12”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [12] Takeda, 1997, Proc. Natl. Acad. Sci. U. S. A. source
Classified as probably not a substantial claim.
Premisecitation§ AbstractLiver regeneration after a two-thirds partial hepatectomy provides an excellent in vivo model for studying cell cycle progression and cell proliferation.
“Liver regeneration after a two-thirds partial hepatectomy provides an excellent in vivo model for studying cell cycle progression and cell proliferation (1”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [1] Michalopoulos, 1997, Science source
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ AbstractSTAT3 belongs to the family of STAT transcription factors which mediate the cellular response to a variety of cytokines and growth factors including IL-6.
“Signal transducer and activator of transcription 3 (STAT3) belongs to the family of STAT transcription factors which mediate the cellular response to a variety of cytokines and growth factors including IL-6 (6-8”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ AbstractAmong the knock-out mouse models now available, only STAT3 plays an essential role in early embryonic development.
“From the knock-out mouse models now available, only STAT3 plays an essential role in early embryonic development (12”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [12] Takeda, 1997, Proc. Natl. Acad. Sci. U. S. A. source
May combine two claims.
Premisecitation§ AbstractThere are two peaks of MAPK activation during regeneration, one at early G1 and the other during mid-late G1 phase.
“There are two peaks of MAPK activation during regeneration, one at early G1 and the other during mid-late G1 phase.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [47] Talarmin, 1999, Mol. Cell. Biol. source
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone given§ RESULTSThe upper band observed in the cyclin E blot is most likely the phosphorylated and inactive form of cyclin E.
“The upper band observed in the cyclin E blot (Fig. 7) was most likely the phosphorylated and inactive form of cyclin E.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisecitation§ AbstractIn rat liver the second peak of MAPK activation occurs around 10.5 h, whereas in mouse liver it is around 24 h posthepatectomy, corresponding to a later S phase onset in the mouse liver.
“In rat liver, the second peak of activation occurs around 10.5 h, whereas in mouse liver it is around 24 h posthepatectomy, corresponding to a later S phase onset in the mouse liver.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [47] Talarmin, 1999, Mol. Cell. Biol. source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisecitation§ AbstractThe STAT-binding element in the JunB promoter does not bind or respond to STAT1.
“the STAT-binding element in the JunB promoter does not bind or respond to STAT1 (27”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [27] Coffer, 1995, Oncogene
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ AbstractThe STAT1 knock-out has a specific defect in the interferon-γ response.
“The STAT1 knock-out has a specific defect in the interferon-γ response (46”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [46] Meraz, 1996, Cell source
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ AbstractThe tissue-specific distribution of some STATs may contribute to their functional specificity.
“the tissue-specific distribution of some STATs may also contribute to their functional specificity (45”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45] Zhong, 1994, Proc. Natl. Acad. Sci. U. S. A. source
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DISCUSSIONA constitutively active form of STAT3 causes cellular transformation in immobilized fibroblasts.
“Furthermore, a constitutively active form of STAT3 causes cellular transformation in immobilized fibroblasts (26”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [26] Bromberg, 1999, Cell source
The paper relies on this without support.
The STAT3 conditional deletion in the liver is specific to hepatocytes and does not affect other liver cell types.
“The albumin promoter was chosen to drive the Cre recombinase to obtain liver-specific deletion of the STAT3 gene.”
The paper relies on this without support.
The STAT1 DNA binding activity observed in Alb+STAT3fl/fl livers represents functional STAT1 signaling capable of compensating for STAT3 loss.
“Unlike in control livers, STAT1 was activated in STAT3 conditional-mutant livers posthepatectomy.”
The paper relies on this without support.
The immediate-early gene expression changes at 2 h posthepatectomy are causally responsible for the subsequent hepatocyte DNA synthesis at 40 h.
“This is the first in vivo evidence that STAT3 promotes cell cycle progression and cell proliferation by up-regulating immediate-early growth response genes.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Successful liver regeneration depends on an intact TNF-NFκB-IL-6-STAT3 pathway.
“Successful LR depends on an intact TNF-NFκB-IL-6-STAT3 pathway.”
From A20 promotes liver regeneration by decreasing SOCS3 expression to enhance IL-6/STAT3 proliferative signals (2013) · cites this paper as [27]
The Abstract reports that hepatocyte DNA synthesis was impaired without STAT3, but liver regeneration still occurred. The Discussion likewise says liver mass was restored despite deficient DNA synthesis. These findings contradict the claim that successful regeneration depends on an intact pathway through STAT3. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredIL-6 is the central trigger of liver regeneration via phosphorylation/activation of STAT3.
“IL-6, produced following hepatectomy by Kupffer cells and hepatocytes (25), is the central trigger of LR via phosphorylation/activation of STAT3 (27).”
From A20 promotes liver regeneration by decreasing SOCS3 expression to enhance IL-6/STAT3 proliferative signals (2013) · cites this paper as [27]
The Abstract calls IL-6 one of the most important initiators of liver regeneration and says STAT3 is induced in an IL-6-dependent fashion. It also reports that regeneration still occurred without STAT3 and that some IL-6 effects are mediated by other pathways. The paper supports IL-6–STAT3 signaling as an important contributor, but not the stronger claim that it is the central trigger of regeneration via STAT3 alone. (LLM, conf=0.88)
Experimental — accuracy not yet measuredThe effect of liver-specific Stat3 deletion on liver regeneration was relatively modest.
“By contrast, the effect of liver-specific Stat3 deletion was relatively modest (71, 72)”
From Senescent hepatic stellate cells promote liver regeneration through IL-6 and ligands of CXCR2 (2022) · cites this paper as [71]
Cites
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080 · see citing works
Experimental pathology of the liver
Higgins, G. (1931) · Medical Entomology and Zoology · Cited by 4,057 · see citing works
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979 · see citing works
Michalopoulos, G. K., & DeFrances, M. C. (1997) · Science · doi:10.1126/science.276.5309.60 · Cited by 2,828 · see citing works
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790 · see citing works
Zhong, Z., Wen, Z., & Darnell, J. E. (1994) · Science · doi:10.1126/science.8140422 · Cited by 2,070 · see citing works
TRANSCRIPTIONAL RESPONSES TO POLYPEPTIDE LIGANDS: The JAK-STAT Pathway
Schindler, C., & Darnell, J. E. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003201 · Cited by 1,808 · see citing works
Meraz, M. A., White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81288-x · Cited by 1,656 · see citing works
Essential role of Stat6 in IL-4 signalling
Takeda, K., Tanaka, T., Shi, W., Matsumoto, M., Minami, M., Kashiwamura, S.-I., Nakanishi, K., Yoshida, N., Kishimoto, T., & Akira, S. (1996) · Nature · doi:10.1038/380627a0 · Cited by 1,557 · see citing works
Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice
Cressman, D. E., Greenbaum, L. E., DeAngelis, R. A., Ciliberto, G., Furth, E. E., Poli, V., & Taub, R. (1996) · Science · doi:10.1126/science.274.5291.1379 · Cited by 1,536 · see citing works
Self-citationSTATs: Signal Transducers and Activators of Transcription
Ihle, J. N. (1996) · Cell · doi:10.1016/s0092-8674(00)81277-5 · Cited by 1,381 · see citing works
Targeted disruption of the mouse <i>Stat3</i> gene leads to early embryonic lethality
Takeda, K., Noguchi, K., Shi, W., Tanaka, T., Matsumoto, M., Yoshida, N., Kishimoto, T., & Akira, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3801 · Cited by 1,323 · see citing works
Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene
Shimoda, K., van Deursent, J., Sangster, M. Y., Sarawar, S. R., Carson, R. T., Tripp, R. A., Chu, C., Quelle, F. W., Nosaka, T., Vignali, D. A. A., et al. (1996) · Nature · doi:10.1038/380630a0 · Cited by 1,278 · see citing works
Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice
Kaplan, M. H., Sun, Y.-L., Hoey, T., & Grusby, M. J. (1996) · Nature · doi:10.1038/382174a0 · Cited by 1,240 · see citing works
Stat5a is mandatory for adult mammary gland development and lactogenesis.
Liu, X., Robinson, G. W., Wagner, K. U., Garrett, L., Wynshaw-Boris, A., & Hennighausen, L. (1997) · Genes & Development · doi:10.1101/gad.11.2.179 · Cited by 1,111 · see citing works
Association and Activation of Jak-Tyk Kinases by CNTF-LIF-OSM-IL-6 β Receptor Components
Stahl, N., Boulton, T. G., Farruggella, T., Ip, N. Y., Davis, S., Witthuhn, B. A., Quelle, F. W., Silvennoinen, O., Barbieri, G., Pellegrini, S., et al. (1994) · Science · doi:10.1126/science.8272873 · Cited by 979 · see citing works
Yamada, Y., Kirillova, I., Peschon, J. J., & Fausto, N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1441 · Cited by 944 · see citing works
Enhanced DNA-Binding Activity of a Stat3-Related Protein in Cells Transformed by the Src Oncoprotein
Yu, C.-L., Meyer, D. J., Campbell, G. S., Larner, A. C., Carter-Su, C., Schwartz, J., & Jove, R. (1995) · Science · doi:10.1126/science.7541555 · Cited by 931 · see citing works
Functional interactions between Stat5 and the glucocorticoid receptor
Stöcklin, E., Wissler, M., Gouilleux, F., & Groner, B. (1996) · Nature · doi:10.1038/383726a0 · Cited by 675 · see citing works
STAT proteins: novel molecular targets for cancer drug discovery
Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1204086 · Cited by 643 · see citing works
Takeda, K., Kaisho, T., Yoshida, N., Takeda, J., Kishimoto, T., & Akira, S. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500168 · Cited by 616 · see citing works
The SIF binding element confers sis/PDGF inducibility onto the c‐fos promoter.
Wagner, B. J., Hayes, T. E., Hoban, C. J., & Cochran, B. H. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07898.x · Cited by 592 · see citing works
Takeda, K., Kaisho, T., Yoshida, N., Takeda, J., Kishimoto, T., & Akira, S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4652 · Cited by 584 · see citing works
Cooperation of Stat2 and p300/CBP in signalling induced by interferon-α
Bhattacharya, S., Eckner, R., Grossman, S., Oldread, E., Arany, Z., D'Andrea, A., & Livingston, D. M. (1996) · Nature · doi:10.1038/383344a0 · Cited by 493 · see citing works
Seidel, H. M., Milocco, L. H., Lamb, P., Darnell, J. E., Stein, R. B., & Rosen, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.3041 · Cited by 415 · see citing works
Ohmori, Y., Schreiber, R. D., & Hamilton, T. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.23.14899 · Cited by 413 · see citing works
Stat3 and Stat4: members of the family of signal transducers and activators of transcription.
Zhong, Z., Wen, Z., & Darnell, J. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4806 · Cited by 397 · see citing works
Activation and Association of Stat3 with Src in v-Src-Transformed Cell Lines
Cao, X., Tay, A., Guy, G. R., & Tan, Y. H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1595 · Cited by 359 · see citing works
Cooperative transcriptional activity of Jun and Stat3 beta, a short form of Stat3.
Schaefer, T. S., Sanders, L. K., & Nathans, D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9097 · Cited by 357 · see citing works
Alonzi, T., Maritano, D., Gorgoni, B., Rizzuto, G., Libert, C., & Poli, V. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.5.1621-1632.2001 · Cited by 329 · see citing works
Self-citationJak-STAT Signaling Induced by the v- <i>abl</i> oncogene
Danial, N. N., Pernis, A., & Rothman, P. B. (1995) · Science · doi:10.1126/science.7569929 · Cited by 325 · see citing works
Gouilleux-Gruart, V, Gouilleux, F., Desaint, C., Claisse, J., Capiod, J., Delobel, J., Weber-Nordt, R., Dusanter-Fourt, I., Dreyfus, F., Groner, B., et al. (1996) · Blood · doi:10.1182/blood.v87.5.1692.1692 · Cited by 316 · see citing works
Rapid activation of the stat3 transcription complex in liver regeneration
Cressman, D. E., Diamond, R. H., & Taub, R. (1995) · Hepatology · doi:10.1002/hep.1840210531 · Cited by 314 · see citing works
Self-citationGreenbaum, L. E., Li, W., Cressman, D. E., Peng, Y., Ciliberto, G., Poli, V, & Taub, R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3135 · Cited by 270 · see citing works
Self-citationStat1 Depends on Transcriptional Synergy with Sp1
Look, D. C., Pelletier, M. R., Tidwell, R. M., Roswit, W. T., & Holtzman, M. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.51.30264 · Cited by 268 · see citing works
Talarmin, H., Rescan, C., Cariou, S., Glaise, D., Zanninelli, G., Bilodeau, M., Loyer, P., Guguen-Guillouzo, C., & Baffet, G. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6003 · Cited by 265 · see citing works
Components of a stat recognition code: Evidence for two layers of molecular selectivity
Schindler, U., Wu, P., Rothe, M., Brasseur, M., & McKnight, S. L. (1995) · Immunity · doi:10.1016/1074-7613(95)90013-6 · Cited by 246 · see citing works
Nielsen, M., Kaltoft, K., Nordahl, M., Röpke, C., Geisler, C., Mustelin, T., Dobson, P., Svejgaard, A., & Ødum, N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6764 · Cited by 220 · see citing works
Hemmann, U., Gerhartz, C., Heesel, B., Sasse, J., Kurapkat, G., Grötzinger, J., Wollmer, A., Zhong, Z., Darnell, J., Graeve, L., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.12999 · Cited by 197 · see citing works
Cornell, R. P., Liljequist, B. L., & Bartizal, K. F. (1990) · Hepatology · doi:10.1002/hep.1840110603 · Cited by 178 · see citing works
Autoregulation of the Stat3 Gene through Cooperation with a cAMP-responsive Element-binding Protein
Ichiba, M., Nakajima, K., Yamanaka, Y., Kiuchi, N., & Hirano, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.6132 · Cited by 175 · see citing works
Leu, J. I., Crissey, M. A. S., Leu, J. P., Ciliberto, G., & Taub, R. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.2.414-424.2001 · Cited by 134 · see citing works
Self-citationLi, W., Liang, X., Leu, J. I., Kovalovich, K., Ciliberto, G., & Taub, R. (2001) · Hepatology · doi:10.1053/jhep.2001.24431 · Cited by 114 · see citing works
Self-citationMohn, K. L., Melby, A. E., Tewari, D. S., Laz, T. M., & Taub, R. A. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.3.1393 · Cited by 107 · see citing works
Self-citation(1995) · PubMed · Cited by 105 · see citing works
Synergistic activation of the germline epsilon promoter mediated by Stat6 and C/EBP beta.
Mikita, T., Kurama, M., & Schindler, U. (1998) · PubMed · Cited by 62 · see citing works
Synergistic Activation of the Germline ε Promoter Mediated by Stat6 and C/EBPβ
Mikita, T., Kurama, M., & Schindler, U. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.4.1822 · Cited by 58 · see citing works
Niwa‐Kawakita, M., Abramowski, V., Kalamarides, M., Thomas, G. D., & Giovannini, M. (2000) · genesis · doi:10.1002/(sici)1526-968x(200002)26:2 · Cited by 22 · see citing works
Flagged first, then by citations
1 of the 49 references couldn’t be matched to a known paper.
Research works printed but not linked: 4
- Higgins, 1931, Arch. Pathol., 12, 186
- Mohn, 1991, Mol. Cell. Biol., 11, 1393
- Coffer, 1995, Oncogene, 10, 985
- Roselli, 1998, Am. J. Physiol., 275, G1472
Cited by
Sorted by citations
Michalopoulos, G. K. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21172 · Cited by 1,384 · see citing works
Fausto, N., Campbell, J. S., & Riehle, K. J. (2006) · Hepatology · doi:10.1002/hep.20969 · Cited by 1,378 · see citing works
Liver regeneration: from myth to mechanism
Taub, R. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1489 · Cited by 1,567 · see citing works
Self-citationDominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome
Minegishi, Y., Saito, M., Tsuchiya, S., Tsuge, I., Takada, H., Hara, T., Kawamura, N., Ariga, T., Pasic, S., Stojković, O., et al. (2007) · Nature · doi:10.1038/nature06096 · Cited by 987 · see citing works
Mechanisms of Acetaminophen-Induced Liver Necrosis
Hinson, J., Roberts, D. W., & James, L. P. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00663-0_12 · Cited by 993 · see citing works
The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer
Naugler, W. E., & Karin, M. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.12.007 · Cited by 730 · see citing works
Signal Transducer and Activator of Transcription‐3, Inflammation, and Cancer
Aggarwal, B. B., Kunnumakkara, A. B., Harikumar, K. B., Gupta, S. R., Tharakan, S. T., Koca, C., Dey, S., & Sung, B. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04911.x · Cited by 652 · see citing works
Zenewicz, L. A., Yancopoulos, G. D., Valenzuela, D. M., Murphy, A. J., Karow, M. L., & Flavell, R. A. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.023 · Cited by 628 · see citing works
“Triggering both of these well-described pathways leads to activation of cell survival genes that are involved in promoting cellcycle progression and cellular transformation and in preventing apoptosis, as well as specifically involved in liver regeneration (Haga et al., 2005; Li et al., 2002).”
BackgroundNuclear Receptor-Dependent Bile Acid Signaling Is Required for Normal Liver Regeneration
Huang, W., Ma, K., Zhang, J., Qatanani, M., Cuvillier, J., Liu, J., Dong, B., Huang, X., & Moore, D. D. (2006) · Science · doi:10.1126/science.1121435 · Cited by 645 · see citing works
Met provides essential signals for liver regeneration
Borowiak, M., Garratt, A. N., Wüstefeld, T., Strehle, M., Trautwein, C., & Birchmeier, C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403412101 · Cited by 497 · see citing works
Molecular physiology of bile acid signaling in health, disease, and aging
Perino, A., Demagny, H., Velazquez-Villegas, L., & Schoonjans, K. (2021) · Physiological Reviews · doi:10.1152/physrev.00049.2019 · Cited by 481 · see citing works
Transcription Factors in Liver Development, Differentiation, and Regeneration
Costa, R. H., Kalinichenko, V. V., Holterman, A. L., & Wang, X. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.034 · Cited by 408 · see citing works
The EGF receptor is required for efficient liver regeneration
Natarajan, A., Wagner, B., & Sibilia, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704126104 · Cited by 320 · see citing works
Subramaniam, A., Shanmugam, M. K., Perumal, E., Li, F., Nachiyappan, A., Dai, X., Swamy, S. N., Ahn, K. S., Kumar, A. P., Tan, B. K. H., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.10.002 · Cited by 281 · see citing works
“between the Alb+and Alb- STAT3 fl/fl livers is smaller at about 3-fold [150].”
BackgroundRegulation of liver regeneration by growth factors and cytokines
Böhm, F., Köhler, U. A., Speicher, T., & Werner, S. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000085 · Cited by 275 · see citing works
“A more severe defect in hepatocyte proliferation following PH was observed in another liver-specific Stat3 knockout strain in which Cre expression was driven by the albumin promoter (Li et al, 2002).”
BackgroundCytokines, STATs and liver disease.
Gao, B. (2005) · PubMed · Cited by 271 · see citing works
Signal Transducer and Activator of Transcription 3 in Liver Diseases: A Novel Therapeutic Target
Wang, H., Lafdil, F., Kong, X., & Gao, B. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.536 · Cited by 268 · see citing works
“Rapid activation of STAT3 has been well-documented during liver regeneration after PHx or liver injury [59,84-86].”
BackgroundInteraction of staphylococci with bone
Wright, J. A., & Nair, S. P. (2009) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2009.10.003 · Cited by 258 · see citing works
Mao, S. A., Glorioso, J. M., & Nyberg, S. L. (2014) · Translational research · doi:10.1016/j.trsl.2014.01.005 · Cited by 245 · see citing works
“Studies in liver-specific stat3null mice demonstrate a significant contribution of the IL-6-induced STAT3 pathway to immediate-early gene expression.(35) This observed decline in immediateearly gene expression in the stat3-null mice was similar but not identical to the IL-6 knockout mice gene expression.”
Principles of Liver Regeneration and Growth Homeostasis
Michalopoulos, G. K. (2012) · Comprehensive physiology · doi:10.1002/cphy.c120014 · Cited by 267 · see citing works
Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms
Haga, S., Terui, K., Zhang, H. Q., Enosawa, S., Ogawa, W., Inoue, H., Okuyama, T., Takeda, K., Akira, S., Ogino, T., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17970 · Cited by 237 · see citing works
“Though targeted disruption of the Stat3 gene actually leads to early embryonic lethality (10), studies have been done using mice with conditional knockout (liver, lymphocyte) of Stat3 (10, 11).”
BackgroundInfluentialThe STAT3 isoforms α and β have unique and specific functions
Maritano, D., Sugrue, M. L., Tininini, S., Dewilde, S., Strobl, B., Fu, X., Murray-Tait, V., Chiarle, R., & Poli, V. (2004) · Nature Immunology · doi:10.1038/ni1052 · Cited by 234 · see citing works
“with transgenic mice that express Cre recombinase under the control of the liver-specific Alb promoter (called Alb Cre here”
BackgroundSelf-citationKnockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells
Konnikova, L., Kotecki, M., Kruger, M. M., & Cochran, B. (2003) · BMC Cancer · doi:10.1186/1471-2407-3-23 · Cited by 217 · see citing works
“Due to the transient nature of cytokine and growth factor signaling and the presence of proteins such as SOCS, suppressor of cytokine signaling, and PIAS, protein inhibitor of activated STAT, that inhibit of STAT3 signaling, STAT3 activation under normal physiological conditions is transient, lasting anywhere from sev…”
Hepatoprotection via the IL-6/Stat3 pathway
Taub, R. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19974 · Cited by 217 · see citing works
“Conditional Stat3 knockout mice have been used to show that Stat3 is an important component of the IL-6 response during liver regeneration and the acute-phase response, but Stat3 does not account for all of the effects of IL-6, particularly those that are mediated by MAPK activation (14).”
Self-citationFang, Y., Gupta, V., Karra, R., Holdway, J. E., Kikuchi, K., & Poss, K. D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309810110 · Cited by 190 · see citing works
Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon-γ)
Sun, R., & Gao, B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.08.055 · Cited by 187 · see citing works
Cui, Y., Hosui, A., Sun, R., Shen, K., Gavrilova, O., Chen, W., Cam, M. C., Gao, B., Robinson, G. W., & Hennighausen, L. G. (2007) · Hepatology · doi:10.1002/hep.21713 · Cited by 184 · see citing works
Horiguchi, N., Wang, L., Mukhopadhyay, P., Park, O., Jeong, W.-I., Lafdil, F., Osei-Hyiaman, D., Moh, A., Fu, X.-Y., Pacher, P., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.016 · Cited by 185 · see citing works
Platelets Promote Liver Regeneration in Early Period after Hepatectomy in Mice
Murata, S., Ohkohchi, N., Matsuo, R., Ikeda, O., Myronovych, A., & Hoshi, R. (2007) · World Journal of Surgery · doi:10.1007/s00268-006-0772-3 · Cited by 177 · see citing works
STAT proteins – Key regulators of anti-viral responses, inflammation, and tumorigenesis in the liver
Gao, B., Wang, H., Lafdil, F., & Feng, D. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.01.029 · Cited by 179 · see citing works
“For example, inhibition of hepatic STAT3, mediated through STAT3 or gp130 deletion, reduced liver regeneration after partial hepatectomy [60,61,69,70].”
BackgroundMethodSeki, E., Tsutsui, H., Iimuro, Y., Naka, T., Son, G., Akira, S., Kishimoto, T., Nakanishi, K., & Fujimoto, J. (2005) · Hepatology · doi:10.1002/hep.20603 · Cited by 173 · see citing works
Acute inflammation stimulates a regenerative response in the neonatal mouse heart
Han, C., Nie, Y., Lian, H., Liu, R., He, F., Huang, H., & Hu, S. (2015) · Cell Research · doi:10.1038/cr.2015.110 · Cited by 169 · see citing works
The roles of innate immune cells in liver injury and regeneration.
Dong, Z., Wei, H., Sun, R., & Tian, Z. (2007) · PubMed · Cited by 167 · see citing works
Walz, C., Ahmed, W. B., Lazarides, K., Betancur, M., Patel, N. K., Hennighausen, L. G., Zaleskas, V. M., & Etten, R. A. V. (2012) · Blood · doi:10.1182/blood-2011-12-397554 · Cited by 166 · see citing works
“Jude Children's Research Hospital, Memphis TN).(25)”
Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3
Riehle, K. J., Campbell, J. S., McMahan, R. S., Johnson, M. M., Beyer, R. P., Bammler, T. K., & Fausto, N. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20070820 · Cited by 161 · see citing works
Nakamura, K., Nonaka, H., Saito, H., Tanaka, M., & Miyajima, A. (2004) · Hepatology · doi:10.1002/hep.20086 · Cited by 157 · see citing works
Waris, G., Turkson, J., Hassanein, T., & Siddiqui, A. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1569-1580.2005 · Cited by 153 · see citing works
“It is generally believed that STAT-3 is involved in liver regeneration and growth regulation ( 28 ), but its role in HCV replication has not been reported.”
BackgroundRetractedMoh, A., Iwamoto, Y., Chai, G.-X., Zhang, S. S.-M., Kano, A., Yang, D. D., Zhang, W., Wang, J., Jacoby, J. J., Gao, B., et al. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700630 · Cited by 147 · see citing works
“01 between the L-Stat3 / and Stat3f/+ mice. www.laboratoryinvestigation.org | Laboratory Investigation | Volume 87 October 2007 1023 0 10 20 30 40 50 60 70 24 40 48 72 Time after PH (hr) B rd U p os iti ve n uc le i ( % ) * WT L-Stat3-/- DAPI Brdu Merge 3 days 60 days WT L-Stat3-/- Figure 4 Liver regeneration after PH…”
InfluentialSchattenberg, J. M., Galle, P. R., & Schuchmann, M. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01324.x · Cited by 144 · see citing works
“TNF-mediated regeneration involves activation of IL-6 and STAT3 (37, 38).”
BackgroundMassive Liver Growth in Mice Induced by Systemic Interleukin 6 Administration
Zimmers, T. A., McKillop, I. H., Pierce, R. H., Yoo, J.-Y., & Koniaris, L. G. (2003) · Hepatology · doi:10.1053/jhep.2003.50318 · Cited by 140 · see citing works
Li, W.-C., Ye, S., Sun, R.-X., Liu, Y.-K., Tang, Z.-Y., Kim, Y., Karras, J., & Zhang, H. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0484 · Cited by 142 · see citing works
Self-citationRajendran, P., Ong, T. H., Chen, L.-X., Li, F., Shanmugam, M. K., Vali, S., Abbasi, T., Kapoor, S., Sharma, A., Kumar, A., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1123 · Cited by 135 · see citing works
“Also, conditional STAT3 knock-out in different organs and tissues have been developed by various groups (62).”
BackgroundFujiyoshi, M., & Ozaki, M. (2010) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1007/s00534-010-0304-2 · Cited by 124 · see citing works
“To elucidate the mechanisms by which STAT3 regulates proliferation, liver-specific STAT3-deficient mice were created [35] because systemic STAT3 deficiency was lethal in early embryonic stages [36].”
BackgroundMatsuo, R., Nakano, Y., & Ohkohchi, N. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e318211caf8 · Cited by 122 · see citing works
Identification of Transcriptional Networks during Liver Regeneration
White, P., Brestelli, J. E., Kaestner, K. H., & Greenbaum, L. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410844200 · Cited by 120 · see citing works
Cytokines in alcoholic liver disease
An, L., Wang, X., & Cederbaum, A. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0814-6 · Cited by 69 · see citing works
Concerted Functions of Gab1 and Shp2 in Liver Regeneration and Hepatoprotection
Bard-Chapeau, E. A., Yuan, J., Droin, N. M., Long, S., Zhang, E. E., Nguyen, T. V., & Feng, G. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02253-05 · Cited by 115 · see citing works
“Activation of Stat3 has been shown to contribute to hepatocyte proliferation and liver regeneration posthepatectomy (7, 25).”
BackgroundMolecular Mechanism of Liver Development and Regeneration
Tanimizu, N., & Miyajima, A. (2007) · International review of cytology · doi:10.1016/s0074-7696(06)59001-1 · Cited by 112 · see citing works
Desbois‐Mouthon, C., Wendum, D., Cadoret, A., Rey, C., Leneuve, P., Blaise, A., Housset, C., Tronche, F., Bouc, Y. L., & Holzenberger, M. (2006) · The FASEB Journal · doi:10.1096/fj.05-4704fje · Cited by 113 · see citing works
Diesen, D. L., & Kuo, P. C. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2009.09.019 · Cited by 108 · see citing works
“The NOS inhibitors, aminoguanidine and L-NMMA, demonstrate the need for NO in DNA synthesis [21], while other factors, including cytokine IL-6, TNF-α, NF-κB, and STAT3, also appear to be important in liver regeneration [2,29,33,36,97,169].”
BackgroundSun, C., Gao, W., Liu, J., Cheng, H., & Hao, J. (2020) · Respiratory Research · doi:10.1186/s12931-020-01477-y · Cited by 109 · see citing works
Leu, J. I.-J., Crissey, M. A. S., Craig, L. E., & Taub, R. A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.4.1251-1259.2003 · Cited by 108 · see citing works
“Regaining of liver mass despite deficient DNA synthesis is a general phenomenon in animal models that are defective in liver regeneration that most likely results from hypertrophy of hepatocytes despite G1/S arrest (4, 9, 20 , 38).”
BackgroundSelf-citationHaga, S., Ogawa, W., Inoue, H., Terui, K., Ogino, T., Igarashi, R., Takeda, K., Akira, S., Enosawa, S., Furukawa, H., et al. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.027 · Cited by 108 · see citing works
“In liver-specific STAT3-KO (LS3-KO) mice, no abnormalities of liver development or structure were observed, but they showed reduced mitogenic response following PH [19].”
BackgroundPregnane X receptor is essential for normal progression of liver regeneration†
Dai, G., He, L., Bu, P., & Wan, Y. Y. (2008) · Hepatology · doi:10.1002/hep.22129 · Cited by 114 · see citing works
Fibroblast growth factor 15 deficiency impairs liver regeneration in mice.
Kong, B., Huang, J., Zhu, Y., Li, G., Williams, J. A., Shen, S., Aleksunes, L., Richardson, J., Apte, U., Rudnick, D. A., et al. (2014) · American Journal of Physiology - Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00337.2013 · Cited by 107 · see citing works
“STAT3 has been shown to be critical in liver regeneration (7, 18).”
Ozaki, M. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.10.007 · Cited by 101 · see citing works
Hepatitis C Virus and Hepatocellular Carcinoma: When the Host Loses Its Grip
Goto, K., Suarez, A. A. R., Wrensch, F., Baumert, T. F., & Lupberger, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093057 · Cited by 105 · see citing works
“Similarly to EGFR, STAT3 plays a central role in the tight regulation of this process, as observed in animal models of partial hepatectomy [66].”
BackgroundCampbell, J. S., Riehle, K. J., Brooling, J. T., Bauer, R. L., Mitchell, C., & Fausto, N. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2522 · Cited by 99 · see citing works
Liao, Y., Shikapwashya, O., Shteyer, E., Dieckgraefe, B. K., Hruz, P. W., & Rudnick, D. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407969200 · Cited by 97 · see citing works
p21 is required for dextrose-mediated inhibition of mouse liver regeneration #
Weymann, A., Hartman, E., Gazit, V. A., Wang, C., Glauber, M., Turmelle, Y. P., & Rudnick, D. A. (2009) · Hepatology · doi:10.1002/hep.22979 · Cited by 94 · see citing works
Adiponectin Signaling Pathways in Liver Diseases
Gamberi, T., Magherini, F., Modesti, A., & Fiaschi, T. (2018) · Biomedicines · doi:10.3390/biomedicines6020052 · Cited by 96 · see citing works
“In particular, the activation of the JAK-STAT3 pathway by IL-6 plays a key role in liver regeneration [92].”
BackgroundDectin-1 Regulates Hepatic Fibrosis and Hepatocarcinogenesis by Suppressing TLR4 Signaling Pathways
Seifert, L., Deutsch, M., Alothman, S., Alqunaibit, D., Werba, G., Pansari, M., Pergamo, M., Ochi, A., Torres-Hernandez, A., Levie, E., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.058 · Cited by 95 · see citing works
“These cytokines, in turn, induce the phosphorylation of STAT3 in hepatocytes, leading to their proliferation (Li et al., 2002).”
BackgroundLiver Regeneration is Impaired in Lipodystrophic Fatty Liver Dystrophy Mice
Gazit, V. A., Weymann, A., Hartman, E., Finck, B. N., Hruz, P. W., Tzekov, A., & Rudnick, D. A. (2010) · Hepatology · doi:10.1002/hep.23920 · Cited by 93 · see citing works
JAK/STAT signalling mediates cell survival in response to tissue stress
Fortezza, M. L., Schenk, M., Cosolo, A., Kolybaba, A. M., Grass, I., & Classen, A.-K. (2016) · Development · doi:10.1242/dev.132340 · Cited by 89 · see citing works
“…for regeneration in tissues as diverse as the grasshopper leg to the mouse liver (Yamada et al., 1997; Bando et al., 2013; Cressman et al., 1996; Li et al., 2002; Wuestefeld et al., 2003; Zhao et al., 2014), dissecting the function of this highly conserved pathway is essential for our…”
BackgroundSingh, A. K., Rooge, S. B., Varshney, A., et al. (2017) · Hepatology · doi:10.1002/hep.29690 · Cited by 91 · see citing works
Control of Growth During Regeneration
Sun, G., & Irvine, K. D. (2014) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-391498-9.00003-6 · Cited by 88 · see citing works
Otu, H. H., Naxerova, K., Ho, K. J., Can, H., Nesbitt, N. T., Libermann, T. A., & Karp, S. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608441200 · Cited by 88 · see citing works
Senescent hepatic stellate cells promote liver regeneration through IL-6 and ligands of CXCR2
Cheng, N., Kim, K.-H., & Lau, L. F. (2022) · JCI Insight · doi:10.1172/jci.insight.158207 · Cited by 87 · see citing works
Sun, R., Tian, Z., Kulkarni, S., & Gao, B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5648 · Cited by 86 · see citing works
“Studies from liver-specific knockout mice suggest that IL-6/gp130/ STAT3 promote cell proliferation (13) and protect against liver injury induced by partial hepatectomy, (14), injection of CCl4 (15), or LPS (16).”
BackgroundMarshall, K. M., He, S., Zhong, Z., Atkinson, C., & Tomlinson, S. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131902 · Cited by 85 · see citing works
“IL-6 expression is dependent on TNF-induced NF-B activation, and IL-6–induced activation of STAT3 plays a role in cell cycle progression (Cressman et al., 1996; Yamada et al., 1997; Li et al., 2002; Blindenbacher et al., 2003).”
BackgroundRole of Growth Hormone (GH) in Liver Regeneration
Pennisi, P. A., Kopchick, J. J., Thorgeirsson, S. S., LeRoith, D., & Yakar, S. (2004) · Endocrinology · doi:10.1210/en.2004-0655 · Cited by 85 · see citing works
“After partial hep- atectomy, the activation of cytokine and growth factor signaling pathways leads to the induction of transcription factor complexes such as nuclear factor- B, c-Myc, signal transducer and activator of transcription-3 (STAT3), cAMPresponsive element modulator, and activating protein-1 (1, 4–9).”
BackgroundInfluentialSasso, G. L., Celli, N., Caboni, M., Murzilli, S., Salvatore, L., Morgano, A., Vacca, M., Pagliani, T., Parini, P., & Moschetta, A. (2009) · Hepatology · doi:10.1002/hep.23436 · Cited by 83 · see citing works
Role for the endoplasmic reticulum stress sensor IRE1α in liver regenerative responses
Liu, Y., Shao, M., Wu, Y., Cheng, Y., Jiang, S., Liu, J., Dai, J., Liu, Y., Li, J. X., Jia, W., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.022 · Cited by 84 · see citing works
“IL-6 activates the JAKs/STAT3 pathway [11], and STAT3 activation plays a crucial part in hepatocyte proliferation during liver regenerative responses [12–14].”
BackgroundGene Deletions and Amplifications in Human Hepatocellular Carcinomas
Nalesnik, M. A., Tseng, G. C., Ding, Y., Xiang, G., Zheng, Z., Yu, Y., Marsh, J. W., Michalopoulos, G. K., & Luo, J. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.12.021 · Cited by 80 · see citing works
“Of interest, STAT3 is a major component of the signaling machinery involved in the entry of hepatocytes into the S phase during liver regeneration.(49) The activation of STAT3 is seen within 1 to 3 hours after partial hepatectomy.”
BackgroundThe Role of Autophagy for the Regeneration of the Aging Liver
Xu, F., Hua, C., Tautenhahn, H., Dirsch, O., & Dahmen, U. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103606 · Cited by 80 · see citing works
S6 kinase 1 is required for rapamycin-sensitive liver proliferation after mouse hepatectomy
Espeillac, C., Mitchell, C., Celton‐Morizur, S., Chauvin, C., Koka, V., Gillet, C., Albrecht, J. H., Desdouets, C., & Pende, M. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44203 · Cited by 80 · see citing works
Yang, S., Wang, S., Wu, C., Yeh, Y., Chai, C., Chunag, S.-C., Sheen, M., & Lee, K.-T. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.036970 · Cited by 78 · see citing works
Impaired liver regeneration in mice lacking methionine adenosyltransferase 1A
Chen, L., Zeng, Y., Yang, H., Lee, T. D., French, S. W., Corrales, F. J., García–Trevijano, E. R., Avila, M. A., Mato, J. M., & Lu, S. C.-L. (2004) · The FASEB Journal · doi:10.1096/fj.03-1204fje · Cited by 78 · see citing works
“STAT-3 is a known downstream target of IL-6 that is also critical for normal liver regeneration to occur (26).”
BackgroundSu, T.-H., Shiau, C.-W., Jao, P., Liu, C.-H., Liu, C.-J., Tai, W.-T., Jeng, Y.-M., Yang, H.-C., Tseng, T.-C., Huang, H.-P., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507499112 · Cited by 78 · see citing works
“In our study, we consistently confirmed the antifibrotic effect of sorafenib and further verified that sorafenib inhibited the STAT3 pathway and downstream cyclin D1 and Mcl-1 expression, which are involved in the cell-cycle regulation and apoptosis (25).”
Backgroundda Silva, C. G., Studer, P., Skroch, M., Mahiou, J., Minussi, D. C., Peterson, C. R., Wilson, S. W., Patel, V. I., Ma, A., Csizmadia, E., et al. (2013) · Hepatology · doi:10.1002/hep.26197 · Cited by 77 · see citing works
“In turn, IL-6 binds to its receptor, activating the JAK/STAT3 (signal transducer and activator of transcription 3) pathway to promote hepatocyte proliferation.3 Accordingly, the superagonistic IL-6/soluble IL-6R fusion protein enhances LR.4 In contrast, mice with targeted disruption of IL-6 demonstrate impaired regene…”
BackgroundInfluentialStat3 is required for the development of skin cancer
Pedranzini, L., Leitch, A., & Bromberg, J. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22800 · Cited by 77 · see citing works
“been shown that phosphorylated Stat1 levels are markedly enhanced in Stat3 null hepatocytes (23).”
BackgroundAdvances in the regulation of liver regeneration
Jia, C. (2011) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.10.87 · Cited by 75 · see citing works
Terui, K., Enosawa, S., Haga, S., Zhang, H. Q., Kuroda, H., Kouchi, K., Matsunaga, T., Yoshida, H., Engelhardt, J. F., Irani, K., et al. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.08.019 · Cited by 75 · see citing works
“The studies using liver-specific conditional knockout mice have indicated that Stat3 is an important initiator of hepatocellular proliferation [20] [21] [22].”
Toll-like receptors in acute liver injury and regeneration
Chen, Y., & Sun, R. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.04.023 · Cited by 74 · see citing works
Mair, M., Zollner, G., Schneller, D., Musteanu, M., Fickert, P., Gumhold, J., Schuster, C., Fuchsbichler, A., Bilban, M., Tauber, S., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.02.049 · Cited by 74 · see citing works
Self-citationNucleus, mitochondrion, or reticulum? STAT3 à La Carte
Avalle, L., & Poli, V. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092820 · Cited by 74 · see citing works
“regeneration [9,10], the stimulation of B lymphocytes differentiation [11], the regulation of the activity of many hematopoietic cells subsets [12–17], the induction of lysosome-mediated apoptosis during mammary gland involution [18], the protection from apoptosis and heart infarction [19], and the maintenance of plur…”
BackgroundSelf-citationDistinctive role of inflammation in tissue repair and regeneration
Choi, B., Lee, C., & Yu, J. (2023) · Archives of Pharmacal Research · doi:10.1007/s12272-023-01428-3 · Cited by 75 · see citing works
Naseem, S., Hussain, T., & Manzoor, S. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.01.002 · Cited by 72 · see citing works
Wen, Y., Feng, D., Wu, H., Liu, W., Li, H., Wang, F., Xia, Q., Gao, W., & Kong, X. (2015) · International Journal of Biological Sciences · doi:10.7150/ijbs.12118 · Cited by 74 · see citing works
“In OPN-/mice, the expression of all three of these genes was repressed due to the reduced activation of the Stat3 pathway, which is the key process that activates hepatocytes to enter the mitosis [35].”
BackgroundIL-6 modulates hepatocyte proliferation via induction of HGF/p21cip1: Regulation by SOCS3
Sun, R., Jaruga, B., Kulkarni, S., Sun, H., & Gao, B. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.171 · Cited by 72 · see citing works
Yin, S., Wang, H., Park, O., Wei, W., Shen, J., & Gao, B. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.01.001 · Cited by 69 · see citing works
“Since hepatic STAT3 has been shown to play an important role in promoting liver regeneration, 13–15 we hypothesized that enhanced STAT3 may contribute to the increased liver regeneration in IL-10 (cid:1) / (cid:1) mice.”
BackgroundFurchtgott, L., Chow, C. C., & Periwal, V. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2009.01.061 · Cited by 70 · see citing works
Sakamori, R., Takehara, T., Ohnishi, C., Tatsumi, T., Ohkawa, K., Takeda, K., Akira, S., & Hayashi, N. (2007) · Hepatology · doi:10.1002/hep.21837 · Cited by 71 · see citing works
Cell Signals Influencing Hepatic Fibrosis
Cong, M., Iwaisako, K., Jiang, C., & Kisseleva, T. (2012) · International Journal of Hepatology · doi:10.1155/2012/158547 · Cited by 70 · see citing works
“Stat3 regulates the expression of cyclin D1 [117], which is required for hepatocyte proliferation [118].”
BackgroundDu, Y. N., Chou, C., Klimstra, D. S., & VARMUS, H. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114022108 · Cited by 67 · see citing works
“Conditional STAT3 knockout mice have been used to show that STAT3 is important for the function of interleukin-6 (IL-6) in liver regeneration (19).”
BackgroundDynamic recruitment of microRNAs to their mRNA targets in the regenerating liver
Schug, J., McKenna, L. B., Walton, G., Hand, N. J., Mukherjee, S., Essuman, K., Shi, Z., Gao, Y. P., Markley, K., Nakagawa, M., et al. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-264 · Cited by 67 · see citing works
“their targets in the regenerating liver, we plotted total gene expression and RISC recruitment for two clusters of genes known to be important in the regenerative process after partial hepatectomy [37].”
BackgroundWANG, X., Bhattacharyya, D., Dennewitz, M. B., Kalinichenko, V. V., ZHOU, Y., Lepe, R., & Costa, R. H. (2003) · Gene Expression · doi:10.3727/000000003108749044 · Cited by 66 · see citing works
“Consistent with this finding, regenerating TTR-FoxM1B TG livers exhibited in1), which are required to mediate hepatocyte proliferation during liver regeneration (29,40) and the MMP- creased expression of Stat3 mRNA, suggesting that”
BackgroundCREBZF as a Key Regulator of STAT3 Pathway in the Control of Liver Regeneration in Mice
Hu, Z., Han, Y., Liu, Y., Zhao, Z., Ma, F., Cui, A., Zhang, F., Liu, Z., Xue, Y., Bai, J., et al. (2020) · Hepatology · doi:10.1002/hep.30919 · Cited by 65 · see citing works
JAK-STAT signaling in hepatic fibrosis
Mair, M. (2011) · Frontiers in bioscience · doi:10.2741/3886 · Cited by 63 · see citing works
“When mice were treated with prolactin (PRL) and subjected to PHx, they displayed premature cell cycle entry of hepatocytes leading to increased numbers of proliferating liver cells when compared to untreated mice (143).”
BackgroundInfluentialWang, H., Zhang, H., Zhang, Z., Huang, B., Cheng, X., Wang, D., la Gahu, Z., Xue, Z., Da, Y., Li, D., et al. (2016) · Scientific Reports · doi:10.1038/srep19445 · Cited by 63 · see citing works
- Authors
- Li, W., Liang, X., Kellendonk, C., Poli, V., & Taub, R.
- Affiliations
- University of Pennsylvania (US)
- Columbia University (US)
- University of Dundee (GB)
- Corresponding author
- Taub, Rebecca
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-08
- Volume
- 277
- Issue
- 32
- Pages
- 28411-28417
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2052467994
- Cited by
- 307
- References
- 49
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 4 · 2023: 11 · 2022: 7 · 2021: 10 · 2020: 10 · 2019: 9 · 2018: 15 · 2017: 10 · 2016: 9 · 2015: 17 · 2014: 13 · 2013: 11 · 2012: 23
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Funders
- National Institutes of Health (5r01dk058315-05, 5p30dk050306-29)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 58315, P30DK50306)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Keywords
- STAT3, liver regeneration, hepatocyte proliferation, interleukin-6, STAT1, partial hepatectomy, G1/S transition, MAPK signaling, hepatocyte DNA synthesis
- MeSH terms
- Animals, Bromodeoxyuridine, Cell Division, DNA, DNA-Binding Proteins, Immunohistochemistry, Liver, Regeneration, Time Factors, Blotting, Northern, Blotting, Western, Signal Transduction, Trans-Activators, DNA, Complementary, Cyclin E, Cyclin D1, Oligonucleotide Array Sequence Analysis, MAP Kinase Signaling System, Hepatocytes, STAT1 Transcription Factor, STAT3 Transcription Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-23.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-23.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review